Join the Micardis group to help and get support from people like you.
Micardis News
FDA Medwatch Alert: Alembic Pharmaceuticals Limited Issues Voluntary Nationwide Recall of Telmisartan Tablets, USP, 20 mg Due to Label Mix-Up
March 24, 2021 – Bridgewater, NJ, Alembic Pharmaceuticals, Inc is voluntarily recalling one lot of Telmisartan Tablets, USP, 20 mg, packaged in 30-count bottles, Lot No. 1905005661 to the consumer...
FDA Medwatch Alert: Angiotensin Receptor Blockers (ARBs): Drug Safety Communication - Drug Safety Review Completed
[UPDATED 06/02/2011] FDA’s meta-analysis of 31 randomized controlled trials comparing ARBs to other treatment found no evidence of an increased risk of incident (new) cancer, cancer-related death, b...
FDA Approves New Use for Micardis in Cardiovascular Risk Reduction
RIDGEFIELD, Conn., Oct. 19 /PRNewswire/ – Boehringer Ingelheim Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) approved the supplemental New Drug Application...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
High Blood Pressure, Hypertension, Cardiovascular Risk Reduction, Prevention of Cardiovascular Disease